Would like to see the details that come out of the Investor Briefing, before judging too much. From the Appendix4C it looks like a fairly big jump on the last quarter for administration and corporate costs, and a fairly insignificant sum spent on marketing. Understand they have self marketed a bit through news interviews etc and have been selling b2b but $9000..... seems quite paltry when they are selling HIV tests direct to the public. A more positive view would be they are saving using partner organisations to move product but a breakdown of where sales are coming from would be nice.
These are my views/opinions only please do your own research
- Forums
- ASX - By Stock
- AT1
- Ann: Appendix 4C - 31 December 2021
Ann: Appendix 4C - 31 December 2021, page-4
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $16.61M |
Open | High | Low | Value | Volume |
2.5¢ | 2.7¢ | 2.5¢ | $13.81K | 531.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 319327 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 158224 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 319327 | 0.025 |
3 | 700383 | 0.024 |
4 | 1016000 | 0.023 |
7 | 1164373 | 0.022 |
4 | 432292 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 158224 | 3 |
0.028 | 206666 | 2 |
0.029 | 452248 | 7 |
0.030 | 632393 | 9 |
0.031 | 159930 | 3 |
Last trade - 14.37pm 09/07/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |